1 |
Amanat A, Al-Belushi B, I Waly M, Al-Moundhri M, A Burney Ik (2013). Dietary and lifestyle factors and risk of non-Hodgkin's lymphoma in Oman. Asian Pac J Cancer Prev, 14, 841-8.
DOI
ScienceOn
|
2 |
Amoori N, Mirzaei M, Cheraghi M(2014). Incidence of cancers in Kuzestan province of Iran: trend from 2004 to 2008. Asian Pac J Cancer Prev, 15, 8345-9.
DOI
|
3 |
Ansell SM, Armitage J (2005). Non-Hodgkin lymphoma: diagnosis and treatment. Proc Mayo Clinic, 80, 1087-97.
DOI
|
4 |
Baker JA, Weiss JR, Czuczman MS, et al (2005). Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control, 16, 301-8.
DOI
|
5 |
Baecklund E, Iliadou A, Askling J, et al (2006). Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum, 54, 692-701.
DOI
|
6 |
Binesh F, Akhavan A, Behniafard N, Atefi A (2014). Clinicopathologic and survival characteristics of childhood and adolescent non Hodgkin's lymphoma in Yazd, Iran. Asian Pac J Cancer Prev, 15, 1585-8.
DOI
|
7 |
Boffetta P, de Vocht F (2007). Occupation and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 16, 369-72.
DOI
|
8 |
Broccia G, Cocco P, Casula P (2001). Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993. Haematologica, 86, 58-63.
|
9 |
Cerhan JR, Anderson KE, Janney CA, et al (2003). Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer, 106, 784-8.
DOI
|
10 |
Chang ET, Smedby KE, Hjalgrim H, et al (2005). Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol, 162, 965-74.
DOI
|
11 |
Chia SE, Wong KY, Tai BC (2012). Occupation and risk of non-Hodgkin's lymphoma in Singapore. Occup Med, 62, 29-33.
DOI
|
12 |
Clarke CA, Glaser SL(2002). Changing incidence of nonhodgkin lymphomas in the United States. Cancer. 94, 2015-23.
DOI
ScienceOn
|
13 |
Devesa SS, Fears T (1992). Non-Hodgkin's lymphoma time trends: United States and international data. Cancer research, 52, 5432-40.
|
14 |
Erber E, Lim U, Maskarinec G, Kolonel LN(2009). Common immune-related risk factors and incident non-Hodgkin lymphoma: The multiethnic cohort. Int J Cancer, 125, 1440-5.
DOI
|
15 |
Ekstrom-Smedby K (2006). Epidemiology and etiology of non-Hodgkin lymphoma--a review. Acta Oncol, 45, 258-71.
DOI
|
16 |
Flick ED, Chan KA, Bracci PM, Holly EA (2006). Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiol, 497, 164-504.
|
17 |
Goldin LR, Bjorkholm M, Kristinsson SY, Turesson I, Landgren O (2009). Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica, 94, 647-53.
DOI
|
18 |
Hernandez BY, Green MD, Cassel KD, et al (2010). Cancer Research Center Hotline: Preview of Hawai 'i Cancer Facts and Figures 2010. Hawaii Med J, 69, 223.
|
19 |
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
DOI
|
20 |
Hoshida Y, Xu J-X, Fujita S, et al (2007). Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medicatio. J Rheumatol, 34, 322-31.n
|
21 |
Karami K, Cheraghi M, Amori N, Pedram M, Sobhani A (2014). Common cancers in Khuzestan province, South West of Iran, during 2005-2011. Asian Pac J Cancer Prev, 15, 9475-8.
DOI
|
22 |
Kato I, Koenig KL, Shore RE, et al (2002). Use of antiinflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL)(United States). Cancer Causes Control, 13, 965-74.
DOI
|
23 |
Rothwell PM, Fowkes FGR, Belch JF, et al (2011). Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet, 377, 31-41.
DOI
|
24 |
Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, et al (2012). Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet, 379, 1602-12.
DOI
|
25 |
Sangrajrang S, Renard H, Kuhaprema T, et al (2011). Personal use of hair dyes--increased risk of non-Hodgkin's lymphoma in Thailand. Asian Pac J Cancer Prev, 12, 2393-6.
|
26 |
Setoguchi S, Solomon DH, Weinblatt ME, et al (2006). Tumor necrosis factor antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum, 54, 2757-64.
DOI
|
27 |
Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics. CA Cancer J Clin, 61, 212-36.
DOI
|
28 |
Teras LR, Gapstur SM, Patel AV, et al (2013). Aspirin and other nonsteroidal anti-inflammatory drugs and risk of non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 22, 422-8.
DOI
|
29 |
Thun MJ, Jacobs EJ, Patrono C (2012). The role of aspirin in cancer prevention. Nat Rev Clin Oncol, 9, 259-67.
DOI
ScienceOn
|
30 |
Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L (2006). Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs. Cancer Detect Prev, 30, 99-101.
DOI
|
31 |
Zekri AR, Hassan ZK, Bahnassy AA et al (2013). Gene expression profiling of non-Hodgkin lymphomas. Asian Pac J Cancer Prev, 14, 4393-8.
DOI
|
32 |
Zelenetz AD, Abramson JS, Advani RH, et al (2010). Non-Hodgkin's lymphomas. J Nat Compr Cancer Netw, 8, 288-334.
|
33 |
Yildirim M, Karakilinc H, Yildiz M, et al (2013). Non-Hodgkin lymphoma and pesticide exposure in Turkey. Asian Pacific J Cancer Prev, 14, 3461-3.
DOI
ScienceOn
|